International Clinical Trial: First-line treatment of recurrent / metastatic head and neck squamous cell carcinoma with paclitaxel polymer micelles for injection, cisplatin combined with immune checkpoint inhibitors : a single-arm

Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134839) titled 'First-line treatment of recurrent / metastatic head and neck squamous cell carcinoma with paclitaxel polymer micelles for injection, cisplatin combined with immune checkpoint inhibitors : a single-arm' on Oct. 21.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The First Affiliated Hospital of Wenzhou Medical University

Condition: Recurrent / metastatic head and neck squamous cell carcinoma

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2026-10-21

Target Sample Size: test group:37;

Countries of Recruitment: China

To know more, visit https://www.chict...